SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy.

Saved in:
Bibliographic Details
Title: SGLT-2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T-Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes-Related Hematological Malignancy.
Authors: Morichika K; Division of Endocrinology Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine Graduate School of Medicine University of the Ryukyus Ryukyus Japan., Tamaki K; Division of Endocrinology Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine Graduate School of Medicine University of the Ryukyus Ryukyus Japan., Fukushima T; Laboratory of Immunohematology School of Health Sciences Faculty of Medicine University of the Ryukyus Ryukyus Japan., Masuzaki H; Division of Endocrinology Diabetes and Metabolism, Hematology and Rheumatology, Second Department of Internal Medicine Graduate School of Medicine University of the Ryukyus Ryukyus Japan.
Source: EJHaem [EJHaem] 2025 Sep 08; Vol. 6 (5), pp. e70109. Date of Electronic Publication: 2025 Sep 08 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2688-6146
DOI:10.1002/jha2.70109